Altimmune Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ALT Nasdaq 2834 http://www.altimmune.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Altimmune Inc

Altimmune Appoints Will Brown as Chief Financial Officer - Jun 12th, 2019 6:00 am
Altimmune Announces Successful Pre-IND Meeting with FDA - Jun 10th, 2019 6:00 am
Altimmune Announces Important Additions to its Patent Portfolio for HepTcell and ALT-702 Programs - Jun 5th, 2019 6:00 am
Altimmune Announces First Quarter 2019 Financial Results and Provides a Business Update - May 14th, 2019 2:15 pm
Altimmune to Announce First Quarter 2019 Financial Results on May 15 - May 8th, 2019 6:00 am
Altimmune To Present NasoVAX Phase 2 Data at the World Vaccine Congress in Washington, D.C. - Apr 11th, 2019 7:27 am
Altimmune, Inc. to Host Earnings Call - Apr 2nd, 2019 4:30 am
Altimmune Announces Financial Results for the Year Ended December 31, 2018 and Provides Corporate Update - Apr 1st, 2019 2:20 pm
Altimmune to Announce Year End 2018 Financial Results on April 2 - Mar 21st, 2019 2:15 pm
Altimmune News: ALT Stock Skyrockets on Positive Flu Vaccine Data - Mar 19th, 2019 10:21 am
Altimmune Announces Positive Results from NasoVAX Extension Study - Mar 19th, 2019 5:00 am
Altimmune to Participate at 31st Annual ROTH Conference - Mar 14th, 2019 7:00 am
Altimmune Announces Closing of $14 Million Registered Direct Offering - Mar 12th, 2019 11:34 am
Altimmune Announces $14 million Registered Direct Offering - Mar 8th, 2019 7:29 am
Altimmune Announces Presentation of HepTcell Phase 1 Results at The International Liver Congress™ in Vienna, Austria - Jan 29th, 2019 6:00 am
Today's Research Reports on Trending Tickers: Sage Therapeutics and Altimmune - Dec 14th, 2018 5:00 am
Altimmune Announces Clinical Program Updates and Plans for Pipeline Expansion - Dec 13th, 2018 5:01 am
Altimmune Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Nov 30th, 2018 4:06 pm
Altimmune Appoints Vipin K. Garg, Ph.D. as its New President and Chief Executive Officer - Nov 27th, 2018 7:00 am